June 27 (Bloomberg) — Thomas Watkins, chief executive officer of Human Genome Sciences Inc., talks about Human Genome’s Benlysta therapy for Lupus. Watkins …
June 27 (Bloomberg) — Thomas Watkins, chief executive officer of Human Genome Sciences Inc., talks about Human Genome’s Benlysta therapy for Lupus. Watkins …